MeSH tree: C15.378.243.750
A new study published in JCI Insight suggests that interleukin-7 (IL-7), a key immune-boosting cytokine, may help critically ill COVID-19 patients by reducing life-threatening secondary infections. Led by Richard S. Hotchkiss, ...
Apr 1, 2025
0
19
The U.S. Food and Drug Administration has removed one hurdle faced by patients with schizophrenia when filling prescriptions for the antipsychotic medication clozapine.
Mar 3, 2025
0
21
For a child battling cancer, an unexpectedly high temperature can initiate a race against time to reach providers who can treat and monitor symptoms. And for families in low- and middle-income communities in Mexico, pediatric ...
Jan 28, 2025
0
17
An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate (MTX), according to a new study by investigators at Mass General Brigham.
Jan 6, 2025
0
14
A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality. On average, it took eight days to recover for patients ...
Nov 14, 2024
0
31
A multi-institutional study made up of 26 researchers led by the University of Melbourne has discovered that iron-reducing deferiprone accelerates cognitive decline in patients with early Alzheimer's disease. This unexpected ...
RCCS San Raffaele Scientific Institute in Milan researchers have discovered that hematopoietic stem cells (HSCs) adapt their lineage commitment during gene therapy based on the underlying genetic disease.
Chemotherapy is a powerful cancer medication—but it can also be a very challenging treatment. It works by killing fast-growing cancer cells but kills healthy cells too, so it's important to know how to care for your body ...
Oct 1, 2024
0
16
Current diagnostic guidelines for a rare type of lymphoma miss a subset of patients with the disease, according to a Northwestern Medicine study published in the journal Blood.
Sep 23, 2024
0
26
The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial efficacy in heavily pretreated patients with advanced or metastatic solid ...
Sep 13, 2024
0
33
